Akebia Therapeutics AKBA
NASDAQ AKBA
$0.54 -0.04 (-6.22%)
As of: Nov 12, 2026 · 12:51 PM EST

Akebia Therapeutics (AKBA) Return on Invested Capital [ROIC] (2020 - 2026)

Updated

Akebia Therapeutics' Return on Invested Capital [ROIC] came in at -20.05% for Q2 2026, down 26.79 percentage points from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Return on Invested Capital [ROIC] (2020 - 2026) Analysis & Trends

For FY2025, Akebia Therapeutics' Return on Invested Capital [ROIC] was 66.79%.

  • The Q2 2026 figure represents the lowest quarterly Return on Invested Capital [ROIC] since Q3 2020.
  • Business Quant data shows AKBA's Return on Invested Capital [ROIC] at 6.73% (Q1 2026), 27.63% (Q4 2025) and 21.44% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Akebia Therapeutics 149.86 Mn -512.48 Mn 30.54 Mn -42.74%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -42.74%
Jun 30, 2026 -20.05%
Mar 31, 2026 6.73%
Dec 31, 2025 27.63%
Sep 30, 2025 21.44%
Sep 30, 2020 -91.35%
Jun 30, 2020 -82.86%
Mar 31, 2020 -56.44%
API Access

Akebia Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=AKBA&period=max&api_key=YOUR_API_KEY